Goetz and Choong Describe the Need for Adjuvant Endocrine Therapy in ER-positive Breast Cancer 

Season 8 Episode 16  ·  Jan 23, 2023, 08:15 PM
Headliner
Share
Subscribe

Drs Goetz and Choong discuss the potential for adjuvant endocrine therapy omission in patients with estrogen receptor–positive breast cancer who have a pathologic complete response to neoadjuvant chemotherapy.

Share
Subscribe
Next
FDA Approval Insights: Nadofaragene Firadenovec in BCG-Unresponsive NMIBC
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air